4/A//SEC Filing
Eiger BioPharmaceuticals, Inc. 4/A
Accession 0001209191-16-141544
CIK 0001305253operating
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 2:47 PM ET
Size
11.4 KB
Accession
0001209191-16-141544
Insider Transaction Report
Form 4/AAmended
Glenn Jeffrey S
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-03-28+30,000→ 30,000 totalExercise: $15.75Exp: 2026-03-28→ Common Stock (30,000 underlying) - Award
Stock Option (Right to Buy)
2016-03-28+25,000→ 25,000 totalExercise: $15.75Exp: 2026-03-28→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The option vests in equal monthly installments over 12 months measured from March 28, 2016 subject to Reporting Person's continuous service status as of each such date.
- [F2]The option grant was approved by Issuer's board of directors on March 28, 2016, subject to stockholder approval of an amendment of the Issuer's 2013 Equity Incentive Plan (the "Plan") under which the option was granted. Issuer's stockholders approved the amendment to the Plan on August 29, 2016.
- [F3]The option vests in equal monthly installments over 36 months measured from March 28, 2016 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 2:47 PM ET
- Size
- 11.4 KB